Procter & Gamble (NYSE:PG) Releases FY 2026 Earnings Guidance

Procter & Gamble (NYSE:PG) updated its FY 2026 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 6.830-7.090 for the period, compared to the consensus estimate of 6.950. The company issued revenue guidance of $85.1 billion-$88.5 billion, compared to the consensus revenue estimate of $86.6 billion.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. BNP Paribas Exane dropped their target price on shares of Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating on the stock in a research report on Thursday. Bank of America dropped their target price on shares of Procter & Gamble from $171.00 to $167.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. The Goldman Sachs Group dropped their target price on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 8th. JPMorgan Chase & Co. dropped their target price on shares of Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating on the stock in a research report on Friday, April 17th. Finally, Barclays dropped their target price on shares of Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. Twelve equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $162.37.

Procter & Gamble Stock Performance

PG traded up $4.85 during trading on Friday, reaching $150.56. 4,353,640 shares of the company’s stock were exchanged, compared to its average volume of 10,927,083. Procter & Gamble has a fifty-two week low of $137.62 and a fifty-two week high of $170.99. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The business has a 50 day moving average price of $150.56 and a 200 day moving average price of $148.72. The company has a market capitalization of $349.90 billion, a P/E ratio of 22.28, a PEG ratio of 5.50 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter in the previous year, the company earned $1.54 earnings per share. The business’s revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts predict that Procter & Gamble will post 6.96 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 24th will be paid a $1.0885 dividend. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 2.9%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s payout ratio is presently 62.67%.

Insiders Place Their Bets

In other news, CEO Gary A. Coombe sold 36,093 shares of the business’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the sale, the chief executive officer owned 34,994 shares in the company, valued at approximately $5,680,576.02. The trade was a 50.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the business’s stock in a transaction on Friday, February 13th. The shares were sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider owned 44,735 shares in the company, valued at $7,259,595.80. This represents a 25.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 252,715 shares of company stock worth $40,966,904 over the last quarter. Corporate insiders own 0.20% of the company’s stock.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Q3 earnings beat — non-GAAP EPS of $1.59 topped consensus ($1.56), showing year-over-year improvement and beating expectations. Read More.
• Positive Sentiment: Revenue and category strength — reported net sales of ~$21.2B (+7% YoY) with beauty and household staples driving solid volume and premiumization gains. That helped P&G top sales expectations. Read More.
• Positive Sentiment: GAAP uplift and organic growth — company release shows diluted net EPS of $1.63 (including a one-time gain from the Glad JV dissolution) and organic sales +3%, supporting margin resilience. Read More.
• Neutral Sentiment: Guidance maintained but mixed — P&G reiterated FY?2026 EPS guidance of $6.83–$7.09 (consensus ~6.95) and revenue range slightly around consensus; the firm kept its outlook but the midpoint is close to sell?side expectations. Read More.
• Neutral Sentiment: Broad market context lifting stocks — P&G’s premarket strength is occurring alongside a wider market rally led by other big earnings beats, which can amplify the stock move independent of fundamentals. Read More.
• Negative Sentiment: Input?cost headwind — management warned of roughly a $150M hit to annual profit tied to higher input costs related to the Middle East conflict, a near?term margin pressure to watch. Read More.
• Negative Sentiment: Analyst target trims — several banks have trimmed price targets or noted higher resin/input costs (e.g., Morgan Stanley, BNP Paribas, BofA), which may cap upside until cost trends and organic margins are clearer. Read More.

Institutional Investors Weigh In On Procter & Gamble

Several institutional investors and hedge funds have recently made changes to their positions in the company. Brighton Jones LLC lifted its position in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after buying an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. lifted its position in Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after buying an additional 277 shares in the last quarter. Sivia Capital Partners LLC lifted its position in Procter & Gamble by 19.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after buying an additional 1,016 shares in the last quarter. Auxano Advisors LLC lifted its position in Procter & Gamble by 10.8% during the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock worth $1,165,000 after buying an additional 714 shares in the last quarter. Finally, Schnieders Capital Management LLC. lifted its position in Procter & Gamble by 2.8% during the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock worth $4,809,000 after buying an additional 809 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.